Biotechnology News

September 2, 2014

ARDSLEY, N.Y.--(BUSINESS WIRE)--Acorda Therapeutics, Inc. (Nasdaq:ACOR) today announced that Ron Cohen, M.D., President and Chief Executive Officer, and Andrew A. Hindman, Chief Business Development Officer, will present at the Morgan Stanley...

September 2, 2014

HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum Pharmaceuticals to Present Corporate Update at the Morgan Stanley Global Healthcare Conference in New York City on September 9th

September 2, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--SAGE Therapeutics Presents New Preclinical Data on SAGE-217 at Eilat Conference on New Anti-Epileptic Drugs

September 2, 2014

SAN DIEGO--(BUSINESS WIRE)--OncoSec Medical to Present at Five Events in September

September 2, 2014

LOS ANGELES--(BUSINESS WIRE)--CytRx Corporation (Nasdaq:CYTR), a biopharmaceutical research and development company specializing in oncology, today announced that President and CEO Steven A. Kriegsman and Vice President of Business Development...

September 2, 2014

MILAN--(BUSINESS WIRE)--First world implant of the CROWN PRT bioprosthetic aortic valve was performed in Austria at the Salzburg University Clinic.

September 2, 2014

MELBOURNE, Australia--(BUSINESS WIRE)--Specialty pharmaceutical company Hatchtech today announced positive results from its two pivotal Phase 3 clinical studies evaluating Xeglyze™ Lotion as a potential treatment for head lice infestation.

September 2, 2014

GALWAY, Ireland--(BUSINESS WIRE)--Neuravi will introduce the Neuravi Thromboembolic Initiative during a series of workshops on “The Science of Clot” at the ESMINT conference in Nice.

September 2, 2014

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today introduced ClearSeq AML, the first product in the ClearSeq line of next-generation cancer research panels, which targets 48 selected exons in 20 of the most commonly...

September 1, 2014

RYDALMERE, Australia--(BUSINESS WIRE)--Welch Allyn, a leading medical diagnostic device company that delivers pragmatic innovation at the point of care, today introduced the industry's most comprehensive clinical surveillance system designed...

September 1, 2014

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Exelixis, Inc. (NASDAQ:EXEL) today announced top-line results from the final analysis of COMET-1, the phase 3 pivotal trial of cabozantinib in men with metastatic castration-resistant prostate cancer...

September 1, 2014

LONDON & BOSTON & TOKYO--(BUSINESS WIRE)--Evaluate announced the appointment of Alex Karle to the role of Chief Executive Officer. Dr Jonathan de Pass, founder and Chief Executive Officer for the last 18 years, will become Chairman.

September 1, 2014

INGELHEIM, Germany--(BUSINESS WIRE)--For Non-US/Non-UK/Non-Canadian Media Five years on from the first breakthrough presentation of the pivotal RE-LY® clinical trial of Pradaxa® (dabigatran etexilate) for the prevention of stroke in non-valvular...

September 1, 2014

MUNICH--(BUSINESS WIRE)--Diaverum, one of the world’s leading renal care providers today announced changes to its Executive Team and its underlying area structure. The Head of Area Latin America is joining the Executive Team and the new Area...

September 1, 2014

OSLO, Norway--(BUSINESS WIRE)--Nordic Nanovector (the “Company”) announces that the subscription period for the previously announced subsequent repair offering (the “Offering”) will commence today. The subscription period will end on 12 September...

September 1, 2014

CHALFONT ST. GILES, England--(BUSINESS WIRE)--GE Healthcare announced today that VIZAMYL™ (flutemetamol (18F) solution for injection) has received marketing authorisation from the European Commission as a radiopharmaceutical medicinal product...

September 1, 2014

PARIS--(BUSINESS WIRE)--Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) today announced that the U.S. Food and Drug Administration (FDA) has accepted and granted priority review of its supplemental New Drug Application (sNDA) for Somatuline®...

August 31, 2014

BARCELONA--(BUSINESS WIRE)--Treating cardiac patients who have sleep apnoea with positive airway pressure (PAP) therapy shown to reduce mortality up to 38%

August 30, 2014

PRINCETON, N.J. & NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE:BMY) and Pfizer Inc. (NYSE:PFE) today announced results of a pre-specified secondary analysis of the Eliquis Phase 3 AMPLIFY-EXT trial (Apixaban after the initial...

August 29, 2014

ELYRIA, Ohio--(BUSINESS WIRE)--Invacare (NYSE: IVC) announces sale of Altimate Medical to Rockwood Equity Partners for approximately $23,000,000 in cash, subject to an escrow arrangement and certain post-closing adjustments.

August 29, 2014

BOSTON--(BUSINESS WIRE)--Boston Strategics has begun a Phase 1 clinical trial of FUJIFILM’s anti-cancer agent FF-10501 in patients with advanced hematologic malignancies including MDS at the MD Anderson Cancer Center.

August 29, 2014

ST. PAUL, Minn.--(BUSINESS WIRE)--Smiths Medical, a leading global medical device manufacturer, announced today that it is initiating a nationwide recall of certain lots of Portex® Endotracheal Tube Holders sold as stand-alone products and...

August 29, 2014

SARASOTA, Fla.--(BUSINESS WIRE)--BioFlorida's Sarasota-Bradenton Chapter debuts the first BioTech Expo in the region to include a combination Life Science Poster & Vendor Event on the evening of Wednesday, September 10, 2014.

August 29, 2014

IRVINE, Calif.--(BUSINESS WIRE)--BIOLASE, Inc. (BIOL), the world’s leading dental laser manufacturer and distributor, announced today that it held its Annual Meeting of Stockholders on Wednesday, August 27, at the Company's corporate headquarters...

August 29, 2014

CLARENCE, N.Y.--(BUSINESS WIRE)--22nd Century Group (NYSE MKT: XXII) announced that NASCO Products, a licensed tobacco product manufacturer and member of the MSA, entered into a multi-year manufacturing with Smoker Friendly.

August 29, 2014

BRIDGEWATER, N.J.--(BUSINESS WIRE)--Senesco Technologies, Inc. (“Senesco” or the “Company”) (OTCQB:SNTI) today announced the closing of enrollment in its ongoing Phase 1b/2a open-label, multiple-dose, dose-escalation clinical trial of SNS01-T, a...

August 29, 2014

NAARDEN, Netherlands--(BUSINESS WIRE)--Dezima Pharma (‘Dezima’), the biotechnology company developing innovative drugs in the field of dyslipidemia, announced today that it has received very positive results in its Phase 2b TULIP clinical trial,...

August 29, 2014

PARIS--(BUSINESS WIRE)--Regualtory News: The Board of Directors of Ipsen (Euronext: IPN; ADR: IPSEY), chaired by Marc de Garidel, met on 28 August 2014 to approve the financial statements for the first half 2014, published today. The interim...

August 28, 2014

TOKYO--(BUSINESS WIRE)--BioJapan 2014 – World Business Forum – will be held for three days from October 15th (Wed.) to 17th (Fri.), 2014 at Pacifico Yokohama (Exhibition Halls C & D, and Annex Hall). Comprised of exhibition, seminars and...

August 28, 2014

BEDFORD, Mass.--(BUSINESS WIRE)--Ocular Therapeutix (Nasdaq: OCUL), announced financial results for the second quarter ended June 30, 2014.

August 28, 2014

EDMONTON, Alberta--(BUSINESS WIRE)--Radient Technologies Inc. (TSX-V:RTI) (the “Corporation”) announced today that it has released its financial results for the first quarter of its fiscal year ended March 31, 2015. The unaudited financial...

August 28, 2014

MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences will participate in Baird’s 2014 Health Care Conference Thursday, Sept. 4 in New York.

August 28, 2014

ST. PAUL, Minn.--(BUSINESS WIRE)--St. Jude Medical, Inc. (NYSE:STJ) will present at the Morgan Stanley Global Healthcare Conference on Tuesday, Sept. 9, in New York City. Don Zurbay, vice president, finance and chief financial officer, will...

August 28, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Eleven will participate in the Citi 9th Annual Biotech Conference on September 4 and the NewsMakers in the Biotech Industry Conference on September 26.

August 28, 2014

OVERLAND PARK, Kan.--(BUSINESS WIRE)--Netsmart today announced that its myAvatar™ ONC 2014 solution has been certified as an Inpatient Complete EHR, 2014 Edition (Meaningful Use Stage 2). Using the myAvatar CareRecord™, hospitals, including those...

August 28, 2014

PARIS & COPENHAGEN, Denmark--(BUSINESS WIRE)--Regulatory News: Onxeo SA (Paris:ONXEO) (NASDAQ OMX:ONXEO) (Euronext Paris, NASDAQ OMX Copenhagen - ONXEO), an innovative company specialized in the development of drugs for orphan oncology...

August 28, 2014

NEW YORK & CARMIEL, Israel--(BUSINESS WIRE)--Pfizer Inc. (NYSE:PFE) and Protalix BioTherapeutics, Inc. (NYSE-MKT:PLX, TASE:PLX) announced today that the U.S. Food and Drug Administration (FDA) approved ELELYSO™ (taliglucerase alfa) for...

August 28, 2014

LEXINGTON, Mass.--(BUSINESS WIRE)--Acusphere announced the strategic decision to voluntarily withdraw its Marketing Authorization Application (MAA) submitted to the European Medicines Agency’s CHMP for Imagify.

August 28, 2014

ALACHUA, Fla. & SAN DIEGO--(BUSINESS WIRE)--Today Banyan Biomarkers, Inc. announced that the company has licensed its intellectual property related to traumatic brain injury (TBI) biomarkers to Abbott for assessment and verification. The...

August 28, 2014

SAN CLEMENTE, Calif.--(BUSINESS WIRE)--VertiFlex®, Inc., a leading innovator of advanced minimally invasive interventions for spinal stenosis, announced the first patients have been treated in the STEPS Trial

August 28, 2014

CHESHIRE, Conn.--(BUSINESS WIRE)--Alexion Pharmaceuticals (Nasdaq: ALXN) today announced that management will present at two upcoming investor conferences: Robert W. Baird & Co. 2014 Health Care Conference in New York City on Thursday,...

August 28, 2014

SAN DIEGO--(BUSINESS WIRE)--ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines to address unmet medical needs in neurological and related central...

August 28, 2014

ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE MKT:BTX) today announced that it has entered into a collaboration with Susan Thibeault, Ph.D., of the University of Wisconsin and Marc Remacle, M.D. of Louvain University to evaluate BioTime’s...

August 28, 2014

CONCORD, Calif.--(BUSINESS WIRE)--Cerus Corporation (NASDAQ:CERS) announced today that Kevin Green, vice president and chief financial officer, is scheduled to present a corporate update at the Baird 2014 Health Care Conference at 7:55 AM ET on...

August 28, 2014

CHARLOTTESVILLE, Va.--(BUSINESS WIRE)--Tau Therapeutics LLC and Xdynia LLC merge to form Cavion LLC, a clinical-stage platform company developing T-type calcium channel antagonists for oncologic and neurologic diseases.

August 28, 2014

REDWOOD CITY, Calif.--(BUSINESS WIRE)--HeartFlow, Inc. today announced the recent appointment of several key executives including Baird Radford, as chief financial officer; Brent Ness, as chief commercial officer; Robert Eno, as vice president of...